National integration of mental health screening and treatment into specialized care for cystic fibrosis: What predicts success?
anxiety
barriers
consolidated framework for implementation research
depression
dissemination
implementation
mental health coordinators
mental health screening
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
revised:
20
02
2023
received:
15
12
2022
accepted:
15
03
2023
medline:
17
5
2023
pubmed:
5
4
2023
entrez:
4
4
2023
Statut:
ppublish
Résumé
The CF Foundation sponsored competitive awards for Mental Health Coordinators (MHCs) from 2016 to 2018 to implement the international guidelines for mental health screening and treatment in US CF centers. Longitudinal surveys evaluated success in implementing these guidelines using the Consolidated Framework for Implementation Research (CFIR). MHCs completed annual surveys assessing implementation from preparation/basic implementation (e.g., using recommended screeners) to full implementation/sustainability (e.g., providing evidence-based treatments). Points were assigned to questions through consensus, with higher scores assigned to more complex tasks. Linear regression and mixed effects models were used to: (1) examine differences in centers and MHC characteristics, (2) identify predictors of success, (3) model the longitudinal trajectory of implementation scores. A total of 122 MHCs (88.4% responded): Cohort 1, N = 80; Cohort 2, N = 30; and Cohort 3, N = 12. No differences in center characteristics were found. Significant improvements in implementation were observed across centers over time. Years of experience on a CF team was the only significant predictor of success; those with 1-5 years or longer reported the highest implementation scores. Change over time was predicted by >5 years of experience. Implementation of the mental health guidelines was highly successful over time. Funding for MHCs with dedicated time was critical. Longitudinal modeling indicated that CF centers with diverse characteristics could implement them, supported by evidence from the CF Patient Registry showing nearly universal uptake of mental health screening in the United States. Years of experience predicted better implementation, suggesting that education and training of MHCs and retention of experienced providers are critical to success.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1768-1776Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Quittner AL, Goldbeck L, Abbott J, et al. Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of the international depression epidemiological study across nine countries. Thorax. 2014;69(12):1090-1097. doi:10.1136/thoraxjnl-2014-205983.
Graziano S, Spanò B, Majo F, et al. Rates of depression and anxiety in Italian patients with cystic fibrosis and parent caregivers: implementation of the mental health guidelines. Respir Med. 2020;172:106147. doi:10.1016/j.rmed.2020.106147.
Verkleij M, Appelman I, Altenburg J, Twisk J, Quittner AL, Haarman E. Anxiety and depression in Dutch patients with primary ciliary dyskinesia and their caregivers: associations with health-related quality of life. ERJ Open Res. 2021;7(4):00274-02021. doi:10.1183/23120541.00274-2021.
Quittner AL, Varley CD, Henkle E. Non-CF bronchiectasis and nontuberculous mycobacteria: integration of mental health and quality of life into patient care. In: Teneback C, Garcia B, eds. Bronchiectasis. Humana Press, Springer Nature; 2022:211-233.
Bock K, Bendstrup E, Hilberg O, Løkke A. Screening tools for evaluation of depression in chronic obstructive pulmonary disease (COPD). A systematic review. Eur Clin Respir J. 2017;4(1):1332931. doi:10.1080/20018525.2017.1332931
Schechter MS, Ostrenga JS, Fink AK, Barker DH, Sawicki GS, Quittner AL. Decreased survival in cystic fibrosis patients with a positive screen for depression. J Cyst Fibros. 2021;20(1):120-126. doi:10.1016/j.jcf.2020.07.020
Barker DH, Quittner AL. Parental depression and pancreatic enzymes adherence in children with cystic fibrosis. Pediatrics. 2016;137(2):e20152296. doi:10.1542/peds.2015-2296
Barker DH, Quittner AL. A biopsychosocial model of CF: social and emotional functioning, adherence and quality of life. In: Allen J, Panitch H, Rubenstein R, eds. Lung Biology in Health and Disease Series: Cystic Fibrosis. Informa Healthcare; 2010:468-481.
Järvholm S, Ericson P, Gilljam M. Patient acceptance and outcome of mental health screening in Swedish adults with cystic fibrosis. Qual Life Res. 2020;29(6):1579-1585. doi:10.1007/s11136-020-02417-5
Quon BS, Bentham WD, Unutzer J, Chan YF, Goss CH, Aitken ML. Prevalence of symptoms of depression and anxiety in adults with cystic fibrosis based on the PHQ-9 and GAD-7 screening questionnaires. Psychosomatics. 2015;56(4):345-353. doi:10.1016/j.psym.2014.05.017
Quittner AL, Abbott J, Georgiopoulos AM, et al. International committee on mental health; EPOS trial study group. international committee on mental health in cystic fibrosis: cystic fibrosis foundation and european cystic fibrosis society consensus statements for screening and treating depression and anxiety. Thorax. 2016;71(1):26-34. doi:10.1136/thoraxjnl-2015-207488
Abbott J, Havermans T, Jarvholm S, et al. ECFS mental health working group mental health screening in cystic fibrosis centres across Europe. J Cyst Fibros. 2019;18(2):299-303. doi:10.1016/j.jcf.2018.09.003
Landau EC, Verkleij M, Graziano S, et al. ECFS and CFF mental health working Group/Advisory committee mental health screening in cystic fibrosis as an intervention: patient and caregiver feedback on improving these processes. Respir Med. 2022;202:106955. doi:10.1016/j.rmed.2022.106955
Beauchemin M, Cohn E, Shelton RC. Implementation of clinical practice guidelines in the health care setting: a concept analysis. ANS Adv Nurs Sci. 2019;42(4):307-324. doi:10.1097/ANS.0000000000000263
Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8(6):1-72. doi:10.3310/hta8060
Quittner AL, Abbott J, Hussain S, et al. Integration of mental health screening and treatment into cystic fibrosis clinics: evaluation of initial implementation in 84 programs across the United States. Pediatr Pulmonol. 2020;55(11):2995-3004. doi:10.1002/ppul.24949
Safaeinili N, Brown-Johnson C, Shaw JG, Mahoney M, Winget M. CFIR simplified: pragmatic application of and adaptations to the consolidated framework for implementation research (CFIR) for evaluation of a patient-centered care transformation within a learning health system. Learn Health Syst. 2019;4(1):e10201. doi:10.1002/lrh2.10201
Damschroder LJ, Reardon CM, Sperber N, Robinson CH, Fickel JJ, Oddone EZ. Implementation evaluation of the telephone lifestyle coaching (TLC) program: organizational factors associated with successful implementation. Transl Behav Med. 2017;7(2):233-241. doi:10.1007/s13142-016-0424-6
Higgins A, Murphy R, Downes C, et al. Factors impacting the implementation of a psychoeducation intervention within the mental health system: a multisite study using the consolidation framework for implementation research. BMC Health Serv Res. 2020;20(1):1023. doi:10.1186/s12913-020-05852-9
Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. Oxford Academic; 2003.
Cystic Fibrosis Foundation Patient Registry 2020 Annual Data Report Bethesda, Maryland ©2021 Cystic Fibrosis Foundation.
Tanne JH. US task force recommends screening children for anxiety and depression. BMJ. 2022;379:o2490. doi:10.1136/bmj.o2490
US Preventive Services Task Force, Mangione CM, Barry MJ, Nicholson WK, et al. Screening for anxiety in children and adolescents: US preventive services task force recommendation statement. JAMA. 2022;328(14):1438-1444. doi:10.1001/jama.2022.16936
Prieur MG, Christon LM, Mueller A, et al. Promoting emotional wellness in children with cystic fibrosis, part I: child and family resilience. Pediatr Pulmonol. 2021;56(suppl 1):S97-S106. doi:10.1002/ppul.24958
Georgiopoulos AM, Christon LM, Filigno SS, et al. Promoting emotional wellness in children with CF, part II: mental health assessment and intervention. Pediatr Pulmonol. 2021;56(suppl 1):S107-S122. doi:10.1002/ppul.24977
Verkleij M, de Winter D, Hurley MA, Abbott J. Implementing the international committee on mental health in cystic fibrosis (ICMH) guidelines: screening accuracy and referral-treatment pathways. J Cyst Fibros. 2018;17(6):821-827. doi:10.1016/j.jcf.2018.02.005